180 related articles for article (PubMed ID: 24139926)
41. Comparison of mono- and combination antibiotic therapy for the treatment of
Tang SY; Zhang SW; Wu JD; Wu F; Zhang J; Dong JT; Guo P; Zhang DL; Yang JT; Zhang WJ
Exp Ther Med; 2018 Mar; 15(3):2418-2428. PubMed ID: 29456647
[TBL] [Abstract][Full Text] [Related]
42. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
[TBL] [Abstract][Full Text] [Related]
43. Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy.
Corona A; Wilson AP; Grassi M; Singer M
J Antimicrob Chemother; 2004 Oct; 54(4):809-17. PubMed ID: 15375106
[TBL] [Abstract][Full Text] [Related]
44. Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients.
Hachem RY; Chemaly RF; Ahmar CA; Jiang Y; Boktour MR; Rjaili GA; Bodey GP; Raad II
Antimicrob Agents Chemother; 2007 Jun; 51(6):1905-11. PubMed ID: 17387153
[TBL] [Abstract][Full Text] [Related]
45. Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to Pseudomonas aeruginosa: a meta-analysis.
Onorato L; Macera M; Calò F; Cirillo P; Di Caprio G; Coppola N
Int J Antimicrob Agents; 2022 Mar; 59(3):106512. PubMed ID: 34971728
[TBL] [Abstract][Full Text] [Related]
46. Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies.
Zhang Y; Chen XL; Huang AW; Liu SL; Liu WJ; Zhang N; Lu XZ
Emerg Microbes Infect; 2016 Mar; 5(3):e27. PubMed ID: 27004762
[TBL] [Abstract][Full Text] [Related]
47. Polymyxin B versus other antimicrobials for the treatment of pseudomonas aeruginosa bacteraemia.
Kvitko CH; Rigatto MH; Moro AL; Zavascki AP
J Antimicrob Chemother; 2011 Jan; 66(1):175-9. PubMed ID: 20961911
[TBL] [Abstract][Full Text] [Related]
48. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Clin Microbiol Infect; 2005 May; 11(5):415-8. PubMed ID: 15819873
[TBL] [Abstract][Full Text] [Related]
49. The impact of infectious diseases consultation on the management and outcomes of Pseudomonas aeruginosa bacteraemia in adults: a retrospective cohort study.
Chiong F; Wasef MS; Liew KC; Cowan R; Tsai D; Lee YP; Croft L; Harris O; Gwini SM; Athan E
BMC Infect Dis; 2021 Jul; 21(1):671. PubMed ID: 34243714
[TBL] [Abstract][Full Text] [Related]
50. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
51. Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections.
Suárez C; Peña C; Tubau F; Gavaldà L; Manzur A; Dominguez MA; Pujol M; Gudiol F; Ariza J
J Infect; 2009 Apr; 58(4):285-90. PubMed ID: 19297028
[TBL] [Abstract][Full Text] [Related]
52. Risk factors, clinical features, and outcome of Pseudomonas aeruginosa bacteremia in patients with hematologic malignancies: a case-control study.
Vuotto F; Berthon C; Lemaitre N; Duhamel A; Balkaran S; Le Ray E; Micol JB; Faure K; Alfandari S
Am J Infect Control; 2013 Jun; 41(6):527-30. PubMed ID: 23219670
[TBL] [Abstract][Full Text] [Related]
53. Combination therapy for treatment of Pseudomonas aeruginosa bloodstream infections.
Tschudin-Sutter S; Fosse N; Frei R; Widmer AF
PLoS One; 2018; 13(9):e0203295. PubMed ID: 30235247
[TBL] [Abstract][Full Text] [Related]
54. Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection.
Suárez C; Peña C; Gavaldà L; Tubau F; Manzur A; Dominguez MA; Pujol M; Gudiol F; Ariza J
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e73-8. PubMed ID: 20223693
[TBL] [Abstract][Full Text] [Related]
55. Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy.
Siegman-Igra Y; Ravona R; Primerman H; Giladi M
Int J Infect Dis; 1998; 2(4):211-5. PubMed ID: 9763504
[TBL] [Abstract][Full Text] [Related]
56. Short versus prolonged duration of therapy for Pseudomonas aeruginosa bacteraemia: a systematic review and meta-analysis.
Ranganath N; Hassett LC; Saleh OMA; Yetmar ZA
J Hosp Infect; 2024 Jun; 148():155-166. PubMed ID: 38685414
[TBL] [Abstract][Full Text] [Related]
57. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy.
Kim YJ; Jun YH; Kim YR; Park KG; Park YJ; Kang JY; Kim SI
BMC Infect Dis; 2014 Mar; 14():161. PubMed ID: 24655422
[TBL] [Abstract][Full Text] [Related]
58. Impact of antibiotic resistance on outcomes of neutropenic cancer patients with
Albasanz-Puig A; Gudiol C; Parody R; Tebe C; Akova M; Araos R; Bote A; Brunel AS; Calik S; Drgona L; García E; Hemmati P; Herrera F; Ibrahim KY; Isler B; Kanj S; Kern W; Maestro de la Calle G; Manzur A; Marin JI; Márquez-Gómez I; Martín-Dávila P; Mikulska M; Montejo JM; Montero M; Morales HMP; Morales I; Novo A; Oltolini C; Peghin M; Del Pozo JL; Puerta-Alcalde P; Ruiz-Camps I; Sipahi OR; Tilley R; Yáñez L; Gomes MZR; Carratalà J;
BMJ Open; 2019 May; 9(5):e025744. PubMed ID: 31129580
[TBL] [Abstract][Full Text] [Related]
59. Favourable outcomes in episodes of Pseudomonas bacteraemia when associated with tunnelled cuffed catheters (TCCs) in chronic haemodialysis patients.
Golestaneh L; Laut J; Rosenberg S; Zhang M; Mokrzycki MH
Nephrol Dial Transplant; 2006 May; 21(5):1328-33. PubMed ID: 16421157
[TBL] [Abstract][Full Text] [Related]
60. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G
J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
